{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:57:37Z","timestamp":1792641457383,"version":"4.5.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:00:00Z","timestamp":1704844800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/144719\/2019"],"award-info":[{"award-number":["SFRH\/BD\/144719\/2019"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["331151"],"award-info":[{"award-number":["331151"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jconrel.2024.01.015","type":"journal-article","created":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T17:42:52Z","timestamp":1705513372000},"page":"621-636","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Nanoparticles targeting the intestinal Fc receptor enhance intestinal cellular trafficking of semaglutide"],"prefix":"10.1016","volume":"366","author":[{"given":"Soraia","family":"Pinto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahya","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen T.","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Garousi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torbj\u00f6rn","family":"Gr\u00e4slund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"van Ijzendoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9lder A.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Sarmento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2024.01.015_bb0005","series-title":"IDF Diabetes Atlas: 10th Edition","author":"International Diabetes Federation (IDF)","year":"2021"},{"key":"10.1016\/j.jconrel.2024.01.015_bb0010","series-title":"Classification of diabetes mellitus: Global reports","author":"World Health Organization (WHO)","year":"2019"},{"key":"10.1016\/j.jconrel.2024.01.015_bb0015","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1021\/acs.molpharmaceut.9b00308","article-title":"Glucagon-like peptide-1 receptor agonists and strategies to improve their efficiency","volume":"16","author":"Alavi","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0020","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications","volume":"14","author":"Zheng","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/jcpt.13230","article-title":"A review of GLP-1 receptor agonists in type 2 diabetes: a focus on the mechanism of action of once-weekly agents","volume":"45","author":"Cornell","year":"2020","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110708","article-title":"Type II diabetes mellitus: a review on recent drug based therapeutics","volume":"131","author":"Padhi","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0035","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.2337\/dc22-S009","article-title":"Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes \u2014 2022","volume":"45","author":"American Diabetes Association Professional Practice Committee","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jconrel.2024.01.015_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.04.016","article-title":"Prevention of diabetes-associated fibrosis: strategies in FcRn-targeted nanosystems for oral drug delivery","volume":"175","author":"Azevedo","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2019.107520","article-title":"Oral semaglutide in type 2 diabetes","volume":"34","author":"Anderson","year":"2020","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0050","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2020.05.007","article-title":"Systemic delivery of peptides by the oral route: formulation and medicinal chemistry approaches","volume":"157","author":"Brayden","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0055","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar7047","article-title":"Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist","volume":"10","author":"Buckley","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0060","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/ajhp\/zxaa413","article-title":"Management of type 2 diabetes with oral semaglutide: practical guidance for pharmacists","volume":"78","author":"Kane","year":"2021","journal-title":"Am. J. Health-Syst. Pharm."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0065","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.pmatsci.2017.05.001","article-title":"Functionalized materials for multistage platforms in the oral delivery of biopharmaceuticals","volume":"89","author":"Ara\u00fajo","year":"2017","journal-title":"Prog. Mater. Sci."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0070","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jconrel.2016.06.016","article-title":"Nanoparticles for oral delivery: design, evaluation and state-of-the-art","volume":"240","author":"Date","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.01.015_bb0075","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.addr.2011.12.009","article-title":"Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers","volume":"64","author":"Ensign","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0080","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.addr.2017.08.010","article-title":"PEGylation for enhancing nanoparticle diffusion in mucus","volume":"124","author":"Huckaby","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0085","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0090","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ejpb.2018.06.029","article-title":"Surface modification with polyethylene glycol enhances colorectal distribution and retention of nanoparticles","volume":"130","author":"Nunes","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0095","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pharmthera.2016.03.007","article-title":"A comprehensive review of the neonatal Fc receptor and its application in drug delivery","volume":"161","author":"Martins","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0100","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1172\/JCI6968","article-title":"Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line","volume":"104","author":"Dickinson","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0105","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1021\/bi052628y","article-title":"Albumin binding to FcRn: distinct from the FcRn\u2212IgG interaction","volume":"45","author":"Chaudhury","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.jconrel.2024.01.015_bb0110","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1242\/jcs.115.11.2389","article-title":"beta(2)-Microglobulin is important for cell surface expression and pH-dependent IgG binding of human FcRn","volume":"115","author":"Praetor","year":"2002","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0115","doi-asserted-by":"crossref","first-page":"44354","DOI":"10.1021\/acsami.8b20821","article-title":"Microfluidic nanoassembly of bioengineered chitosan-modified FcRn-targeted porous silicon nanoparticles @ hypromellose acetate succinate for oral delivery of antidiabetic peptides","volume":"10","author":"Martins","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2024.01.015_bb0120","first-page":"299","article-title":"Neonatal Fc receptor-targeted lignin-encapsulated porous silicon nanoparticles for enhanced cellular interactions and insulin permeation across the intestinal epithelium","volume":"9","author":"Martins","year":"2022","journal-title":"Bioact. Mat."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0125","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jconrel.2020.08.005","article-title":"Engineered albumin-functionalized nanoparticles for improved FcRn binding enhance oral delivery of insulin","volume":"327","author":"Azevedo","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.01.015_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201800462","article-title":"Engineered multifunctional albumin-decorated porous silicon nanoparticles for FcRn translocation of insulin","volume":"14","author":"Martins","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2024.01.015_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00811","article-title":"Understanding Fc receptor involvement in inflammatory diseases: from mechanisms to new therapeutic tools","volume":"10","author":"Ben Mkaddem","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00682","article-title":"Unraveling the interaction between FcRn and albumin: opportunities for design of albumin-based therapeutics","volume":"5","author":"Sand","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0145","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1248\/cpb.c21-01024","article-title":"The new delivery strategy of albumin carrier utilizing the interaction with albumin receptors","volume":"70","author":"Ishima","year":"2022","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0150","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1073\/pnas.0708960105","article-title":"Reduction of IgG in nonhuman primates by a peptide antagonist of the neonatal Fc receptor FcRn","volume":"105","author":"Mezo","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0155","doi-asserted-by":"crossref","first-page":"16095","DOI":"10.1073\/pnas.1208857109","article-title":"Engineering neonatal Fc receptor-mediated recycling and transcytosis in recombinant proteins by short terminal peptide extensions","volume":"109","author":"Sockolosky","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0160","doi-asserted-by":"crossref","DOI":"10.1002\/biot.201800007","article-title":"Engineered FcRn binding fusion peptides significantly enhance the half-life of a Fab domain in cynomolgus monkeys","volume":"14","author":"Datta-Mannan","year":"2019","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0165","doi-asserted-by":"crossref","first-page":"17110","DOI":"10.1073\/pnas.1417717111","article-title":"An engineered affibody molecule with pH-dependent binding to FcRn mediates extended circulatory half-life of a fusion protein","volume":"111","author":"Seijsing","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0170","article-title":"Functionalizing PLGA and PLGA derivatives for drug delivery and tissue regeneration applications","volume":"7","author":"Martins","year":"2018","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0175","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.colsurfb.2017.07.038","article-title":"Recent applications of PLGA based nanostructures in drug delivery","volume":"159","author":"Mir","year":"2017","journal-title":"Colloids Surf. B"},{"key":"10.1016\/j.jconrel.2024.01.015_bb0180","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jconrel.2021.07.035","article-title":"p28-functionalized PLGA nanoparticles loaded with gefitinib reduce tumor burden and metastases formation on lung cancer","volume":"337","author":"Garizo","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.01.015_bb0185","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1038\/s41598-017-03959-4","article-title":"A new paradigm for antiangiogenic therapy through controlled release of bevacizumab from PLGA nanoparticles","volume":"7","author":"Sousa","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0190","doi-asserted-by":"crossref","first-page":"10122","DOI":"10.1039\/D0SM01011A","article-title":"A spectroscopic and molecular dynamics study on the aggregation process of a long-acting lipidated therapeutic peptide: the case of semaglutide","volume":"16","author":"Venanzi","year":"2020","journal-title":"Soft Matter"},{"key":"10.1016\/j.jconrel.2024.01.015_bb0195","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1038\/nprot.2011.410","article-title":"Generating human intestinal tissue from pluripotent stem cells in vitro","volume":"6","author":"McCracken","year":"2011","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0200","doi-asserted-by":"crossref","first-page":"27694","DOI":"10.1074\/jbc.M110.120667","article-title":"X-ray crystal structures of monomeric and dimeric peptide inhibitors in complex with the human neonatal Fc receptor, FcRn","volume":"285","author":"Mezo","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0205","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jconrel.2016.07.051","article-title":"Role of nanoparticle size, shape and surface chemistry in oral drug delivery","volume":"238","author":"Banerjee","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.01.015_bb0210","doi-asserted-by":"crossref","first-page":"8569","DOI":"10.1016\/j.biomaterials.2012.07.063","article-title":"Size-dependent absorption mechanism of polymeric nanoparticles for oral delivery of protein drugs","volume":"33","author":"He","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.01.015_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2024.01.015_bb0220","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1517\/17425240903579971","article-title":"Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers","volume":"7","author":"Caldorera-Moore","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0225","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1021\/tx400316s","article-title":"Toxicity of polyamines and their metabolic products","volume":"26","author":"Pegg","year":"2013","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0230","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.foodchem.2018.06.148","article-title":"Spermine and spermidine are cytotoxic towards intestinal cell cultures, but are they a health hazard at concentrations found in foods?","volume":"269","author":"Del Rio","year":"2018","journal-title":"Food Chem."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0235","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1039\/c1md00014d","article-title":"Synthesis and efficient siRNA delivery of polyamine-conjugated cationic nucleoside lipids","volume":"2","author":"Patil","year":"2011","journal-title":"MedChemComm"},{"key":"10.1016\/j.jconrel.2024.01.015_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13122058","article-title":"Novel fluorinated spermine and small molecule PEI to deliver anti-PD-L1 and anti-VEGF siRNA for highly efficient tumor therapy","volume":"13","author":"Zhang","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2024.01.015_bb0245","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/978-1-0716-1298-9_22","article-title":"Production and characterization of anti-CCR5 siRNA-loaded polycaprolactone nanoparticles for topical pre-exposure prophylaxis","volume":"2282","author":"Ribeiro","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0250","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1039\/C9NA00308H","article-title":"Hydrophobic ion pairing: encapsulating small molecules, peptides, and proteins into nanocarriers","volume":"1","author":"Ristroph","year":"2019","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0255","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejpb.2020.04.025","article-title":"Hydrophobic ion pairing of a GLP-1 analogue for incorporating into lipid nanocarriers designed for oral delivery","volume":"152","author":"Ismail","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0260","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1007\/s11095-013-1212-3","article-title":"Human and non-human primate intestinal FcRn expression and immunoglobulin G transcytosis","volume":"31","author":"Hornby","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0265","first-page":"840","article-title":"FcRn expression in the human retinal pigment epithelium","volume":"51","author":"Bilsen","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0270","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature09691","article-title":"Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro","volume":"470","author":"Spence","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2024.01.015_bb0275","doi-asserted-by":"crossref","first-page":"2001371","DOI":"10.1002\/smll.202001371","article-title":"Black phosphorus quantum dots cause nephrotoxicity in organoids, mice, and human cells","volume":"16","author":"He","year":"2020","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2024.01.015_bb0280","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1126\/science.1234852","article-title":"Growing self-organizing mini-guts from a single intestinal stem cell: mechanism and applications","volume":"340","author":"Sato","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2024.01.015_bb0285","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature07935","article-title":"Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche","volume":"459","author":"Sato","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2024.01.015_bb0290","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1242\/dev.150201","article-title":"The hope and the hype of organoid research","volume":"144","author":"Huch","year":"2017","journal-title":"Development"},{"key":"10.1016\/j.jconrel.2024.01.015_bb0295","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/ncb3312","article-title":"Organoids as an in vitro model of human development and disease","volume":"18","author":"Fatehullah","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0300","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cell.2016.05.082","article-title":"Modeling development and disease with organoids","volume":"165","author":"Clevers","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2024.01.015_bb0305","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.yexcr.2019.02.017","article-title":"Engineered materials to model human intestinal development and cancer using organoids","volume":"377","author":"Cruz-Acu\u00f1a","year":"2019","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0310","article-title":"Organoids as model for infectious diseases: culture of human and murine stomach organoids and microinjection of Helicobacter pylori","volume":"105","author":"Bartfeld","year":"2015","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0315","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.molmed.2022.02.001","article-title":"Organoid technologies for the study of intestinal microbiota-host interactions","volume":"28","author":"Bozzetti","year":"2022","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0320","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/ibd\/izab292","article-title":"Development of a personalized intestinal fibrosis model using human intestinal organoids derived from induced pluripotent stem cells","volume":"28","author":"Estrada","year":"2022","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0325","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1128\/IAI.00161-15","article-title":"Interaction of Salmonella enterica serovar typhimurium with intestinal organoids derived from human induced pluripotent stem cells","volume":"83","author":"Forbester","year":"2015","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0330","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.183","article-title":"Ex vivo culture of intestinal crypt organoids as a model system for assessing cell death induction in intestinal epithelial cells and enteropathy","volume":"5","author":"Grabinger","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0335","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1038\/s41467-018-05450-8","article-title":"Interleukin-2 induces the in vitro maturation of human pluripotent stem cell-derived intestinal organoids","volume":"9","author":"Jung","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0340","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41422-020-00453-x","article-title":"Establishment of intestinal organoid cultures modeling injury-associated epithelial regeneration","volume":"31","author":"Qu","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0345","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/mi.2014.72","article-title":"A small intestinal organoid model of non-invasive enteric pathogen-epithelial cell interactions","volume":"8","author":"Wilson","year":"2015","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0350","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/jbm.a.36305","article-title":"Intestinal organoids containing poly(lactic-co-glycolic acid) nanoparticles for the treatment of inflammatory bowel diseases","volume":"106","author":"Davoudi","year":"2018","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.jconrel.2024.01.015_bb0355","doi-asserted-by":"crossref","DOI":"10.3390\/md19050282","article-title":"Gut organoid as a new platform to study alginate and chitosan mediated PLGA nanoparticles for drug delivery","volume":"19","author":"Davoudi","year":"2021","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.jconrel.2024.01.015_bb0360","doi-asserted-by":"crossref","first-page":"15858","DOI":"10.1021\/acsnano.1c03707","article-title":"Carbon nanotubes promote the development of intestinal organoids through regulating extracellular matrix viscoelasticity and intracellular energy metabolism","volume":"15","author":"Bao","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.01.015_bb0365","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/gutjnl-2013-306651","article-title":"Development of an enhanced human gastrointestinal epithelial culture system to facilitate patient-based assays","volume":"64","author":"VanDussen","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2024.01.015_bb0370","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.stemcr.2017.10.013","article-title":"Development and characterization of a human and mouse intestinal epithelial cell monolayer platform","volume":"9","author":"Kozuka","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0375","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jcmgh.2017.02.011","article-title":"Self-renewing monolayer of primary colonic or rectal epithelial cells","volume":"4","author":"Wang","year":"2017","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0380","doi-asserted-by":"crossref","first-page":"10140","DOI":"10.1038\/s41598-019-46497-x","article-title":"Self-organized intestinal epithelial monolayers in crypt and villus-like domains show effective barrier function","volume":"9","author":"Altay","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0385","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.879024","article-title":"Reversing epithelial polarity in pluripotent stem cell-derived intestinal organoids","volume":"10","author":"Kakni","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0390","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1016\/j.celrep.2019.01.108","article-title":"Controlling epithelial polarity: a human enteroid model for host-pathogen interactions","volume":"26","author":"Co","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0395","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1038\/s41596-021-00607-0","article-title":"Controlling the polarity of human gastrointestinal organoids to investigate epithelial biology and infectious diseases","volume":"16","author":"Co","year":"2021","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0400","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s42003-021-01901-z","article-title":"Inside-out chicken enteroids with leukocyte component as a model to study host-pathogen interactions","volume":"4","author":"Nash","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0405","article-title":"Culture methods to study apical-specific interactions using intestinal organoid models","volume":"169","author":"Stroulios","year":"2021","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0410","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1053\/j.gastro.2014.09.042","article-title":"In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection","volume":"148","author":"Bartfeld","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2024.01.015_bb0415","article-title":"Real-time measurement of epithelial barrier permeability in human intestinal organoids","volume":"130","author":"Hill","year":"2017","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0420","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jcmgh.2018.05.004","article-title":"A high-throughput organoid microinjection platform to study gastrointestinal microbiota and luminal physiology","volume":"6","author":"Williamson","year":"2018","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0425","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004663","article-title":"CD44 plays a functional role in Helicobacter pylori-induced epithelial cell proliferation","volume":"11","author":"Bertaux-Skeirik","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jconrel.2024.01.015_bb0430","series-title":"Biological Evaluation of Medical Devices \u2014 Part 5: Tests for in vitro cytotoxicity","author":"ISO. ISO 10993-5","year":"2009"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924000191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924000191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T21:33:25Z","timestamp":1738100005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924000191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":86,"alternative-id":["S0168365924000191"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.01.015","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoparticles targeting the intestinal Fc receptor enhance intestinal cellular trafficking of semaglutide","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}